{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:17:49Z","timestamp":1792844269628,"version":"4.5.0"},"publisher-location":"New York, NY","reference-count":12,"publisher":"Springer US","isbn-type":[{"value":"9781071648230","type":"print"},{"value":"9781071648247","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-4824-7_18","type":"book-chapter","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:44:10Z","timestamp":1761547450000},"page":"281-298","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Phenotypic High-Throughput Screening and Drug Efficacy Test Against the Growth of Cryptosporidium parvum In Vitro by qRT-PCR"],"prefix":"10.1007","author":[{"given":"Chenchen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"4","key":"18_CR1","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1128\/AAC.02460-12","volume":"57","author":"K Bessoff","year":"2013","unstructured":"Bessoff K, Sateriale A, Lee KK, Huston CD (2013) Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth. Antimicrob Agents Chemother 57(4):1804\u20131814. https:\/\/doi.org\/10.1128\/AAC.02460-12","journal-title":"Antimicrob Agents Chemother"},{"key":"18_CR2","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3389\/fmicb.2015.00991","volume":"6","author":"H Zhang","year":"2015","unstructured":"Zhang H, Zhu G (2015) Quantitative RT-PCR assay for high-throughput screening (HTS) of drugs against the growth of Cryptosporidium parvum in vitro. Front Microbiol 6:991. https:\/\/doi.org\/10.3389\/fmicb.2015.00991","journal-title":"Front Microbiol"},{"issue":"7561","key":"18_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature14651","volume":"523","author":"S Vinayak","year":"2015","unstructured":"Vinayak S, Pawlowic MC, Sateriale A, Brooks CF, Studstill CJ, Bar-Peled Y, Cipriano MJ, Striepen B (2015) Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum. Nature 523(7561):477\u2013480. https:\/\/doi.org\/10.1038\/nature14651","journal-title":"Nature"},{"issue":"11","key":"18_CR4","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1128\/AAC.49.11.4437-4442.2005","volume":"49","author":"X Cai","year":"2005","unstructured":"Cai X, Woods KM, Upton SJ, Zhu G (2005) Application of quantitative real-time reverse transcription-PCR in assessing drug efficacy against the intracellular pathogen Cryptosporidium parvum in vitro. Antimicrob Agents Chemother 49(11):4437\u20134442. https:\/\/doi.org\/10.1128\/AAC.49.11.4437-4442.2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"18_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1574-6968.1994.tb06833.x","volume":"118","author":"SJ Upton","year":"1994","unstructured":"Upton SJ, Tilley M, Brillhart DB (1994) Comparative development of Cryptosporidium parvum (Apicomplexa) in 11 continuous host cell lines. FEMS Microbiol Lett 118(3):233\u2013236","journal-title":"FEMS Microbiol Lett"},{"issue":"2","key":"18_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1128\/jcm.33.2.371-375.1995","volume":"33","author":"SJ Upton","year":"1995","unstructured":"Upton SJ, Tilley M, Brillhart DB (1995) Effects of select medium supplements on in vitro development of Cryptosporidium parvum in HCT-8 cells. J Clin Microbiol 33(2):371\u2013375","journal-title":"J Clin Microbiol"},{"issue":"2","key":"18_CR7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.2307\/3282084","volume":"73","author":"MJ Arrowood","year":"1987","unstructured":"Arrowood MJ, Sterling CR (1987) Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients. J Parasitol 73(2):314\u2013319","journal-title":"J Parasitol"},{"issue":"1","key":"18_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1128\/jcm.34.1.38-40.1996","volume":"34","author":"P Suresh","year":"1996","unstructured":"Suresh P, Rehg JE (1996) Comparative evaluation of several techniques for purification of Cryptosporidium parvum oocysts from rat feces. J Clin Microbiol 34(1):38\u201340","journal-title":"J Clin Microbiol"},{"issue":"1","key":"18_CR9","first-page":"62","volume":"18","author":"JA Glasel","year":"1995","unstructured":"Glasel JA (1995) Validity of nucleic acid purities monitored by 260nm\/280nm absorbance ratios. BioTechniques 18(1):62\u201363","journal-title":"BioTechniques"},{"issue":"2","key":"18_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/pst.426","volume":"10","author":"JL Sebaugh","year":"2011","unstructured":"Sebaugh JL (2011) Guidelines for accurate EC50\/IC50 estimation. Pharm Stat 10(2):128\u2013134. https:\/\/doi.org\/10.1002\/pst.426","journal-title":"Pharm Stat"},{"issue":"3","key":"18_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011217","volume":"17","author":"B Yang","year":"2023","unstructured":"Yang B, Yan Y, Wang D, Zhang Y, Yin J, Zhu G (2023) On-target inhibition of Cryptosporidium parvum by nitazoxanide (NTZ) and paclitaxel (PTX) validated using a novel MDR1-transgenic host cell model and algorithms to quantify the effect on the parasite target. PLoS Negl Trop Dis 17(3):e0011217. https:\/\/doi.org\/10.1371\/journal.pntd.0011217","journal-title":"PLoS Negl Trop Dis"},{"key":"18_CR12","volume-title":"Validation","author":"PW Iversen","year":"2012","unstructured":"Iversen PW, Benoit Beck B, Yun-Fei Chen Y, Dere W, Devanarayan V, Eastwood BJ, Farmen MW, Iturria SJ, Montrose C, Moore RA, Weidner JR, Sittampalam GS (2012) Validation. Eli Lilly & Company and the National Center for Advancing Translational Sciences. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK53196\/"}],"container-title":["Methods in Molecular Biology","Cryptosporidium"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4824-7_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:45:43Z","timestamp":1779338743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4824-7_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"ISBN":["9781071648230","9781071648247"],"references-count":12,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4824-7_18","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"28 October 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}